Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 17, 2019Nature CommunicationsOpen Access

Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension

View Full Paper
Ask AI
Bookmark
Share

Authors

AWAstrid WeißJustus-Liebig-Universität GießenMNMoritz Christian NeubauerJustus-Liebig-Universität GießenDYDinesh YeraboluJustus-Liebig-Universität Gießen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Weiß et al. (2019) studied this question.

synapsesocial.com/papers/6aa220f2d2b6e29a16d3cf91https://doi.org/10.1038/s41467-019-10135-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Peptide arrays for kinome analysis: New opportunities and remaining challenges2011 · 87 citations
  2. 2Dinaciclib for the treatment of breast cancer2014 · 56 citations
  3. 3Pathogenesis of pulmonary arterial hypertension: lessons from cancer2013 · 206 citations
  4. 4Tyrosine Kinase Inhibitors in Pulmonary Arterial Hypertension: A Double-Edge Sword?2013 · 64 citations